In the BioHarmony Drug Report Database

"Preview" Icon

Fesoterodine

Toviaz (fesoterodine) is a small molecule pharmaceutical. Fesoterodine was first approved as Toviaz on 2007-04-20. It is used to treat urge urinary incontinence in the USA. It has been approved in Europe to treat overactive urinary bladder. Toviaz’s patents are valid until 2027-06-07 (FDA).

 

Trade Name

 

Toviaz
 

Common Name

 

fesoterodine
 

ChEMBL ID

 

CHEMBL1201764
 

Indication

 

overactive urinary bladder, urge urinary incontinence
 

Drug Class

 

Image (chem structure or protein)

Fesoterodine structure rendering